免疫检查点抑制剂治疗晚期恶性腹膜间皮瘤的临床疗效。
Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal Mesothelioma.
机构信息
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston.
出版信息
JAMA Netw Open. 2021 Aug 2;4(8):e2119934. doi: 10.1001/jamanetworkopen.2021.19934.
Abstract
This cohort study examines the clinical efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced malignant peritoneal mesothelioma.
摘要
本队列研究考察了免疫检查点抑制剂（ICI）在晚期恶性腹膜间皮瘤患者中的临床疗效。
Zotero 插件